In a report released yesterday, Wee Kuang Tay from CGS-CIMB reiterated a Buy rating on Q & M Dental Group (Singapore) Limited (QMBN – Research Report), with a price target of S$0.43.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Wee Kuang Tay has given his Buy rating due to a combination of factors surrounding Q & M Dental Group’s strategic moves and market opportunities. The company recently regained full control of EM2AI, a digital solutions provider for dentistry, by acquiring the remaining 51% stake. This acquisition is expected to enhance Q & M’s profitability, as EM2AI has shown a turnaround in financial performance, contributing positively to the company’s net profit.
Additionally, EM2AI’s recent receipt of a medical device license in Australia for its dental AI solutions opens up new market opportunities. This license allows EM2AI to expand its reach and integrate its solutions with established dental providers in Australia, potentially increasing its customer base beyond its current presence in Southeast Asia. These strategic developments, along with Q & M’s plans to expand in key markets like Singapore, Malaysia, and China, underpin the positive outlook for the company’s growth prospects.
According to TipRanks, Kuang Tay is ranked #5481 out of 9395 analysts.